Skip to content

Vivani Medical, Inc.

VANI · XNAS

CIK 1266806fmd_1PF9HK3YM4DYD57BTR0NB95Y9TManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues4873––––00
Cost of revenue1055210––––
Net interest income––––––––––
Gross profit(6)32110––––
Research and development58101351114171618
Selling, general and administrative192122157–––––
Total operating expenses27313735151321272528
Compensation and benefits–––––––131211
Operating income(33)(29)(35)(34)(15)(13)(21)(27)(25)(28)
Other non-operating income (expense)–––––––111
Income before taxes––––––––(23)(27)
Income tax expense––00––––0–
Net income from continuing operations––––––––(23)–
Net income(33)(29)(35)(34)(15)(13)(14)(26)(23)(27)
Vivani Medical, Inc. (VANI) financial statements · FinancialMD